|Previous Section||Back to Table of Contents||Lords Hansard Home Page|
Lord Bach: Mortality figures for the United Kingdom veterans of the 199091 Gulf conflict from 1 April 1991 to 31 December 2002 were published on 9 January 2003 (Official Report, cols. WA 158 WA 160). The latest data, as at 30 June 2003, are shown in Table 1 below. As before, the data for Gulf veterans are compared to that of a control group, known as the era cohort, which is made up of Armed Forces personnel of a similar size, age, gender, service, regular/reservist status and rank who were not deployed. Table 2 provides a detailed breakdown of deaths from cancer (neoplasm) by anatomical site.
On 24 July 2002 (WA 8183) it was announced that the Ministry of Defence was discussing with the University of Manchester a detailed study of the factors underlying the figures for road traffic accident deaths. There are indications that the excess of motor vehicle accident deaths among Gulf veterans occurred principally during the first six years after the cessation of hostilities (to 31 March 1997) and that this trend has reversed in the following six years to 31 March 2003.
Furthermore, the numbers of incidents are relatively small, the information on each accident is insufficiently detailed to allow meaningful analysis and a considerable amount of time has elapsed since 1 April 1991. Therefore, following the advice of the experts that have been consulted, we have decided not to commission the proposed study.
|ICD Chapter||Cause of death||Gulf||Era(13)||Mortality Rate Ratio(14)|
|All cause coded deaths||586||599||0.97|
|I||Infectious and parasitic diseases||4||2||1.99|
|III||Endocrine and immune disorders||1||6||0.20|
|VI||Diseases of the nervous system and sense organs (Note 5)||10||11||0.90|
|VII||Diseases of the circulatory system||82||106||0.77|
|VIII||Diseases of the respiratory system||11||6||1.82|
|IX||Diseases of the digestive system||15||18||0.83|
|IV, XXVI||All other disease-related causes (Note 6)||2||12||0.17|
|EXVII||External causes of injury and poisoning||343||299||1.14|
|Motor vehicle accidents||118||100||1.17|
|Water transport accidents||5||1||4.98|
|Air and space accidents||25||19||1.31|
|Other vehicle accidents||0||1||0.00|
|Accidents due to fire/flames||0||2||0.00|
|Accidents due to natural environmental factors||2||2||1.00|
|Accidents due to submersion/suffocation/foreign bodies||17||7||2.42|
|Late effects of accident/injury||0||2||0.00|
|Suicide and injury undetermined whether||110||103||1.06|
|accidentally or purposely inflicted Homicide||6||5||1.19|
|Injury resulting from the operations of war||3||4||0.75|
|Other deaths for which coded cause data are not yet available||11||10|
|Overseas deaths for which cause data are not available||3||4|
1. Service and ex-Service personnel only.
2. World Health Organisation's International Classification of Diseases 9th revision, 1997.
3. The Era group comprises 53,143 personnel, randomly sampled from all UK Armed Forces personnel in service on 1 January 1991 and who did not deploy to the Gulf. This group is matched to the 53,409 Gulf veterans to reflect the socio-demographic and military composition of the Gulf cohort in terms of age, gender, Service (Army, Royal Navy, Royal Air Force), officer/other rank status, regular/reservist status, and a proxy measure for fitness.
4. Mortality rate ratios differ marginally from the crude deaths ratio owing to some small differences between the Gulf and Era cohorts.
5. These figures include four deaths from motor neurone disease amongst the Gulf cohort and three in the Era group.
6. Includes cases with insufficient information on the death certificate to provide a known cause of death.
|140149||Malignant neoplasm of lip, oral cavity and pharynx||6||4|
|150159||Malignant neoplasm of digestive organs and peritoncum||22||30|
|160165||Malignant neoplasm of respiratory and intrathoracic organs||17||25|
|170175||Malignant neoplasm of bone, connective tissue, skin and breast||14||13|
|179189||Malignant neoplasm of genitourinary organs||3||7|
|190199||Malignant neoplasm of other and unspecified site||21||29|
|200208||Malignant neoplasm of lymphatic and haematopoietic tissue||19||14|
(11) World Health Organisation's International Classification of Diseases 9th revision, Geneva, 1997.
The Minister of State, Office of the Deputy Prime Minister (Lord Rooker): Following a commitment in the 2001 local government White Paper, we are carrying out a wide-ranging review of the balance between central and local sources of funding for local government in England. This review is being steered by a high level group, chaired by my right honourable friend the Member for Greenwich and Woolwich in the other place, which includes senior representatives of central and local government as well as business, the unions, the academic world and the accountancy profession.
To inform the work of the group my right honourable friend the Member for Greenwich and Woolwich is today issuing an invitation to all those interested to submit comments by 30 September 2003. Copies of the invitation letter will be available in the Libraries of the House, the Printed Paper Office and on the website of the Office of the Deputy Prime Minister.
The Parliamentary Under-Secretary of State, Department of Health (Lord Warner): The average degree of consanguinity between brother and half-sister is equivalent to that between blood uncle and niece. In both cases, on average the two related individuals will have one quarter of their genes in common.
Lord Warner: Ministers have received a number of recent written representations from, and on behalf of, the National Association of Health Stores (NAHS) expressing NAHS's concerns over the impact of the Food Supplements Directive and the implementing regulations. In particular, NAHS voice particular concerns over the current composition of the lists of permitted substances in the annexes to the directive and asked that the United Kingdom seek an amendment to the directive.
Ministers have responded recognising those concerns and setting out the Government's view that there was no possibility of negotiations on the directive being reopened. Many member states wanted a much more restrictive regime.
No aspect of the directive needs to be implemented by the industry until 1 August 2005 and the Food Supplements (England) Regulations 2003 make use of flexibility in the directive that means marketing of some products may not be affected until 1 January 2010.
Food supplements containing vitamins and minerals and their sources missing from the positive lists that were on the market when the directive came into force may continue to be marketed beyond 1 August 2005 provided that dossiers to support their addition to the positive lists have been submitted to the European Commission before 12 July 2005 and provided that the European Food Safety Authority has not given a negative opinion on such use.
Lord Warner: The Government's firm position is that safety should be the primary concern, and that maximum limits should be set at levels that are based on scientific risk assessments and not limited by considerations of nutritional need, thus protecting public health without unnecessarily limiting consumer choice or unduly restricting trade.
Article 5 of Directive 2002/46/EC on food supplements sets out principles for setting EU maximum limits for vitamins and minerals in food supplements, although no specific figures have yet been set. Discussion on maximum limits at EU level will follow publication of advice from the European Food Safety Authority. We do not expect the European Commission to issue its proposal on maximum limits before the end of this year.
Back to Table of Contents
Lords Hansard Home Page